NE-Core NTRC

Medicine & Life Sciences

1. Multiple Sclerosis 100%
2. Neuromyelitis Optica 86%
3. Essential Tremor 43%
4. Pediatrics 35%
5. Optic Neuritis 28%
6. Cervical Cord 24%
7. Aquaporin 4 21%
8. African Americans 21%
9. Parkinson Disease 20%
10. acute flaccid myelitis 20%
11. Multiple System Atrophy 18%
12. Hospital Emergency Service 18%
13. Visual Acuity 18%
14. Optical Coherence Tomography 16%
15. Purkinje Cells 16%
16. Pupillary Reflex 16%
17. levodopa drug combination carbidopa 15%
18. Myelin-Oligodendrocyte Glycoprotein 15%
19. Videoconferencing 15%
20. Transverse Myelitis 15%
21. European Continental Ancestry Group 15%
22. Rituximab 15%
23. Cerebellar Cortex 15%
24. Levodopa 14%
25. Remyelination 14%
26. Therapeutics 13%
27. Hashimoto's encephalitis 13%
28. Antipyretics 13%
29. Motor Disorders 13%
30. Bromocriptine 13%
31. Mycophenolic Acid 13%
32. Hospitalized Child 12%
33. Azathioprine 12%
34. Clinical Trials 12%
35. Brain 12%
36. Polysomnography 11%
37. Urban Hospitals 11%
38. Validation Studies 11%
39. Public Hospitals 11%
40. Sleepiness 11%
41. Sensitivity and Specificity 11%
42. Diabetic Retinopathy 11%
43. Immunoglobulin G 10%
44. Immunosuppressive Agents 10%
45. Epilepsy 10%
46. Neurodegenerative Diseases 10%
47. Traumatic Brain Injury 10%
48. Diagnostic Errors 10%
49. Magnetic Resonance Imaging 10%
50. Meta-Analysis 10%
51. Gait 10%
52. Brain Diseases 10%
53. Demyelinating Diseases 9%
54. Skilled Nursing Facilities 9%
55. Acute Disseminated Encephalomyelitis 9%
56. Pupil 9%
57. Spinocerebellar Ataxias 9%
58. Brain Stem 9%
59. Neuroglia 9%
60. Comorbidity 9%
61. Antibodies 8%
62. Economics 8%
63. Recurrence 8%
64. Rehabilitation 8%
65. Population 8%
66. Fever 8%
67. Psychiatry 7%
68. Direction compound 7%
69. Temperature 7%
70. Oxygen 7%
71. Pons 7%
72. Light 7%
73. Prospective Studies 7%
74. Stroke 7%
75. Depression 7%
76. entacapone 6%
77. Patient Health Questionnaire 6%
78. Equipment and Supplies 6%
79. TimeLine 6%
80. Retrospective Studies 6%
81. Myelitis 5%
82. Health Care Outcome Assessment 5%
83. Cerebellum 5%
84. Eye 5%
85. White Matter 5%
86. Outpatients 5%
87. Pragmatic Clinical Trials 5%
88. Mental Status and Dementia Tests 5%